136 related articles for article (PubMed ID: 6157579)
1. Transfer factor treatment in bullous pemphigoid. Impaired T cell function.
Khan A; Ayyar R; Michaelson JD; Weaver RE; Hill NO
Dermatologica; 1980; 161(4):243-9. PubMed ID: 6157579
[TBL] [Abstract][Full Text] [Related]
2. [Immunopathological aspects of autoimmune bullous dermatoses].
Grando SA; Glukhen'kiĭ BT; Kutsenko NS; Kostromin AP; Demidov SV
Vrach Delo; 1987 Sep; (9):94-7. PubMed ID: 3321707
[No Abstract] [Full Text] [Related]
3. Interleukin-2 production in bullous pemphigoid.
Ahmed AR; Hijri K; Arab-Kermani V
Arch Dermatol Res; 1984; 276(5):330-2. PubMed ID: 6385872
[No Abstract] [Full Text] [Related]
4. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
Büdinger L; Borradori L; Yee C; Eming R; Ferencik S; Grosse-Wilde H; Merk HF; Yancey K; Hertl M
J Clin Invest; 1998 Dec; 102(12):2082-9. PubMed ID: 9854043
[TBL] [Abstract][Full Text] [Related]
5. Familial autoimmune enteropathy with circulating anti-bullous pemphigoid antibodies and chronic autoimmune hepatitis.
Lachaux A; Bouvier R; Cozzani E; Loras-Duclaux I; Kanitakis J; Chevallier M; Kaiserlian D
J Pediatr; 1994 Dec; 125(6 Pt 1):858-62. PubMed ID: 7996356
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune reaction in the mechanism of blister formation in bullous pemphigoid.
Takiguchi Y; Kamiyama O; Saito E; Nagao S; Kaneko F; Minagawa T
Dermatologica; 1989; 179 Suppl 1():137. PubMed ID: 2673853
[No Abstract] [Full Text] [Related]
8. Bullous pemphigoid and pemphigus vulgaris.
Patel HP; Anhalt GJ; Diaz LA
Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
[No Abstract] [Full Text] [Related]
9. Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases.
Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Wieczfinska J; Pniewska E; Zebrowski M; Waszczykowska E; Wozniacka A; Eusebio M; Pietruczuk M; Pawliczak R
Mediators Inflamm; 2015; 2015():870428. PubMed ID: 27057091
[TBL] [Abstract][Full Text] [Related]
10. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells.
Teraki Y; Hotta T; Shiohara T
J Invest Dermatol; 2001 Nov; 117(5):1097-102. PubMed ID: 11710918
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease.
Aljasser MI; Sladden C; Crawford RI; Au S
J Cutan Med Surg; 2014; 18(2):123-6. PubMed ID: 24636438
[TBL] [Abstract][Full Text] [Related]
12. [Therapy with transfer factor in a case of recidivating herpes with polymorphous erythema].
García-Calderón PA; Alomar A; García-Calderón JV; Vich JM; De Moragas JM
Med Cutan Ibero Lat Am; 1977; 5(5):361-6. PubMed ID: 368459
[TBL] [Abstract][Full Text] [Related]
13. [Bullous pemphigoid treated by plasma exchange. Open study in 10 patients].
Guillot B; Donadio D; Guilhou JJ; Courren C; Meynadier J
Presse Med; 1983 Sep; 12(30):1855-8. PubMed ID: 6225082
[TBL] [Abstract][Full Text] [Related]
14. [Mechanisms of therapeutic effect of extracorporeal detoxication in autoimmune bullous dermatoses].
Grando SA; Glukhen'kiĭ BT; Romanenko AB; Chaiun OA; Dolia SV
Vestn Dermatol Venerol; 1988; (7):6-11. PubMed ID: 3064487
[No Abstract] [Full Text] [Related]
15. [Effect of transfer factor on the immunity state of patients with bronchopulmonary cancer. A report on 12 cases (author's transl)].
Hainaut J; Challan-Belval P; Haguenauer G; Pellegrin J; Allard P; Kermarec J
Ann Med Interne (Paris); 1979; 130(11):517-21. PubMed ID: 317697
[TBL] [Abstract][Full Text] [Related]
16. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
17. [Bullous pemphigoid in children (author's transl)].
Saurat JH
Sem Hop; 1982 Jun; 58(25):1563-7. PubMed ID: 6287627
[TBL] [Abstract][Full Text] [Related]
18. Emerging treatments for pemphigoid diseases.
Ludwig RJ; Kalies K; Köhl J; Zillikens D; Schmidt E
Trends Mol Med; 2013 Aug; 19(8):501-12. PubMed ID: 23831338
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent cellular cytotoxicity in bullous diseases.
Ahmed AR
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):481-4. PubMed ID: 7042775
[TBL] [Abstract][Full Text] [Related]
20. Localized bullous pemphigoid, a T cell-mediated disease? Electron microscopic and immunologic studies.
van Joost T; Vuzevski VD; ten Kate F; Tank B
Acta Derm Venereol; 1989; 69(4):341-4. PubMed ID: 2568059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
